Key Findings
The Asia Pacific pharmaceutical continuous manufacturing market is predicted to project a CAGR of 10.99% during the forecast period, 2021-2028. The increasing focus of prominent manufacturers with regard to the expansion of their geographic presence in the emerging countries of the region is set to provide ample growth opportunities.

Market Insights
Thailand, China, Vietnam, South Korea, India, Japan, Australia & New Zealand, Indonesia, and Rest of Asia Pacific, are assessed for the Asia Pacific pharmaceutical continuous manufacturing market growth evaluation. The increasing geriatric population of Japan is impacting the government healthcare expenditure. As a result, the government is adopting cost-containment measures like promoting generic drugs and biennial drug pricing revisions. Also, the big pharma companies are collaborating to form joint ventures to meet the expectant high demand for generics. In Australia & New Zealand, the rising expenditure on pharmaceutical products is estimated to drive the market growth. The recent CM (continuous manufacturing) approvals have prioritized solid dose tablet manufacturing. Simultaneously, there has been an increase in the momentum for biologics and active pharmaceutical ingredients (APIs).
In Thailand, the government’s efforts to make the country a leading destination for pharmaceuticals and medical devices and a world-class provider of medical care, is set to benefit market growth. The thriving pharmaceutical industry is attributed to the compliance with the manufacturing standards of the Pharmaceutical Inspection Cooperation Scheme (PIC/S). Owing to such factors, the country is projected to become a more attractive partner for multinational pharmaceutical manufacturers. Such developments and initiatives are expected to contribute to market growth.

Competitive Insights
Some of the major market players include, Pfizer Inc, Glatt GmbH, Gebruder Lodige Maschinenbau GmbH, Munson Machinery Company, Hosokawa Micron Corporation, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments